Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer

Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer

CMTM6 is a critical regulator of cell surface expression of PD-L1 in tumor cells, but little is known about the transcriptional regulation of CMTM6. Here we report that the expression of CMTM6 positively correlates with the epithelial to mesenchymal transition (EMT) score in breast cancer cell lines...

Full description

Bibliographic Details
Main Authors:	Malina Xiao, Meriem Hasmim, Audrey Lequeux, Kris Van Moer, Tuan Zea Tan, Christine Gilles, Brett G. Hollier, Jean Paul Thiery, Guy Berchem, Bassam Janji, Muhammad Zaeem Noman
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Series:	Cancers
Subjects:	breast cancer epithelial to mesenchymal transition snail1 CMTM family immune checkpoints
Online Access:	https://www.mdpi.com/2072-6694/13/5/1165

Similar Items

CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment
by: Tong Zhang, et al.
Published: (2022-07-01)

Expression Analysis of Canine CMTM6 and CMTM4 as Potential Regulators of the PD-L1 Protein in Canine Cancers
by: Hiroto Takeuchi, et al.
Published: (2020-06-01)

Expression and clinical significance of CMTM1 in hepatocellular carcinoma
by: Song Xin, et al.
Published: (2021-01-01)

Current Opinions on the Relationship Between CMTM Family and Hepatocellular Carcinoma
by: Pei Y, et al.
Published: (2023-08-01)

CMTM6 significantly relates to PD-L1 and predicts the prognosis of gastric cancer patients
by: Xin Li, et al.
Published: (2020-08-01)

Co-Expression with Membrane CMTM6/4 on Tumor Epithelium Enhances the Prediction Value of PD-L1 on Anti-PD-1/L1 Therapeutic Efficacy in Gastric Adenocarcinoma
by: Ziqi Wang, et al.
Published: (2021-10-01)

Co-expression of CMTM6 and PD-L1: a novel prognostic indicator of gastric cancer
by: Chao Zhang, et al.
Published: (2021-01-01)

Overexpressed CMTM6 Improves Prognosis and Associated With Immune Infiltrates of Ovarian Cancer
by: Bo Yin, et al.
Published: (2022-01-01)

CMTM Family and Gastrointestinal Tract Cancers: A Comprehensive Review
by: Li J, et al.
Published: (2022-04-01)

Overexpression of CMTM7 inhibits cell growth and migration in liver cancer
by: Zi‐Ming Huang, et al.
Published: (2019-06-01)

CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells
by: Xiaoting Huang, et al.
Published: (2021-03-01)

CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer
by: Fei Xing, et al.
Published: (2023-01-01)

MicroRNA-205 inhibits renal cells apoptosis via targeting CMTM4
by: Hongxia Zhang, et al.
Published: (2015-10-01)

Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma
by: Shengkui Tan, et al.
Published: (2022-08-01)

CMTM7 recognizes an immune-hot tumor microenvironment and predicts therapeutic response of immunotherapy in breast cancer well
by: Xingyu Jiang, et al.
Published: (2022-12-01)

Loss of CMTM6 promotes DNA damage-induced cellular senescence and antitumor immunity
by: Hanfeng Wang, et al.
Published: (2022-12-01)

Prognostic Implications of Pan-Cancer CMTM6 Expression and Its Relationship with the Immune Microenvironment
by: Yanbin Zhao, et al.
Published: (2021-01-01)

CMTM family proteins 1–8: roles in cancer biological processes and potential clinical value
by: Jie Wu, et al.
Published: (2020-08-01)

Expressions of ZNF436, β-catenin, EGFR, and CMTM5 in breast cancer and their clinical significances
by: Zhi Chen, et al.
Published: (2021-01-01)

Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy
by: Sandra Martinez-Morilla, et al.
Published: (2021-01-01)

Increased CMTM6 can predict the clinical response to PD-1 inhibitors in non-small cell lung cancer patients
by: Young Wha Koh, et al.
Published: (2019-10-01)

Identification of prognostic biomarkers in the CMTM family genes of human ovarian cancer through bioinformatics analysis and experimental verification
by: Mengjun Zhang, et al.
Published: (2022-08-01)

CMTM6 is highly expressed in lung adenocarcinoma and can be used as a biomarker of a poor diagnosis
by: Daqi Jia, et al.
Published: (2023-01-01)

CMTM3 protects the gastric epithelial cells from apoptosis and promotes IL-8 by stabilizing NEMO during Helicobacter pylori infection
by: Jing Zhang, et al.
Published: (2023-02-01)

CMTM5 is downregulated and suppresses tumour growth in hepatocellular carcinoma through regulating PI3K-AKT signalling
by: Gang Xu, et al.
Published: (2017-11-01)

CMTM7 inhibits breast cancer progression by regulating Wnt/β-catenin signaling
by: Zhao-Hui Chen, et al.
Published: (2023-02-01)

Loss of the Novel Myelin Protein CMTM5 in Multiple Sclerosis Lesions and Its Involvement in Oligodendroglial Stress Responses
by: Jiangshan Zhan, et al.
Published: (2023-08-01)

CMTM3 suppresses bone formation and osteogenic differentiation of mesenchymal stem cells through inhibiting Erk1/2 and RUNX2 pathways
by: Dongwei Fan, et al.
Published: (2021-11-01)

CMTM Family Genes Affect Prognosis and Modulate Immunocytes Infiltration in Grade II/III Glioma Patients by Influencing the Tumor Immune Landscape and Activating Associated Immunosuppressing Pathways
by: Zeyu Wang, et al.
Published: (2022-02-01)

Research insights into the chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM): their roles in various tumors
by: Sai-Li Duan, et al.
Published: (2024-01-01)

CMTM7 as a novel molecule of ATG14L-Beclin1-VPS34 complex enhances autophagy by Rab5 to regulate tumorigenicity
by: Baocai Liu, et al.
Published: (2021-07-01)

Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
by: Muhammad Zaeem Noman, et al.
Published: (2019-09-01)

Breast cancer cell-derived extracellular vesicles transfer miR-182-5p and promote breast carcinogenesis via the CMTM7/EGFR/AKT axis
by: Chong Lu, et al.
Published: (2021-07-01)

miR-149-5p Regulates Goat Hair Follicle Stem Cell Proliferation and Apoptosis by Targeting the CMTM3/AR Axis During Superior-Quality Brush Hair Formation
by: Jian Wang, et al.
Published: (2020-11-01)

Firing up the cold tumors by targeting Vps34
by: Bassam Janji, et al.
Published: (2020-01-01)

Analysis of CMTM6 and CMTM4 expression as potential regulators of the PD-L1 protein and its association with prognosis in glioma cancer
by: Xue Hui, et al.
Published: (2022-08-01)

SNAI1-dependent upregulation of CD73 increases extracellular adenosine release to mediate immune suppression in TNBC
by: Meriem Hasmim, et al.
Published: (2022-09-01)

A role for EMT in CD73 regulation in breast cancer
by: Meriem Hasmim, et al.
Published: (2022-12-01)

Targeting Cytoprotective Autophagy to Enhance Anticancer Therapies
by: Malina Xiao, et al.
Published: (2021-02-01)

The Circular RNA CircCOL1A1 Functions as a miR-149-5p Sponge to Regulate the Formation of Superior-Quality Brush Hair via the CMTM3/AR Axis
by: Jian Wang, et al.
Published: (2022-02-01)